Cellectricon
Latest round
- Series B
Last raised
- May 2004
Total raised
- $7M
Investors
- 3
About Cellectricon
Cellectricon AB, headquartered in Molndal, Sweden, provides research services that focus on neuroscience drug discovery. Founded by individuals with a robust background in biotechnology, they have undergone strategic pivots to enhance their offerings in the biopharmaceutical sector.3 mn from VINNOVA in September 2006, marking their fifth investment deal.Cellectricon specializes in providing advanced in vitro research services aimed at accelerating neuroscience drug discovery. Their core product offerings include service modules for various neurological conditions, such as Peripheral Neuropathies, Neurodegeneration, Neuroplasticity, and Neuroinflammation. These services leverage innovative technologies and biologically relevant systems to identify new drug targets and optimize lead compounds for pharmaceuticals. Cellectricon primarily serves clients in the biopharmaceutical industry, including research institutions and companies focused on neurological drug development.Cellectricon's revenue structure is primarily based on collaborative research services provided to their clients, which include major pharmaceutical companies and biotech firms.60. Transactions typically involve project-based agreements where clients engage Cellectricon for specific research initiatives tied to their drug development pipelines. The services are structured as direct contracts, often with predefined milestones and deliverables, facilitating ongoing partnerships.Cellectricon is focused on expanding its product offerings and entering new geographical markets.3 mn from VINNOVA is anticipated to support the development of innovative new products aimed at enhancing their service modules. The company plans to strengthen its presence in existing markets while exploring opportunities in emerging regions over the next few years, leveraging these resources to build on their portfolio and service capabilities.
Who invested in Cellectricon
3 investors across 1 round
See all investors in Cellectricon
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
May 26, 2004
Amount
$7M
Investors
Questions about Cellectricon
Who invested in Cellectricon?
Cellectricon has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cellectricon raised?
Cellectricon has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Cellectricon last raise money?
Cellectricon's most recent round on record is a Series B, in May 2004.
What does Cellectricon do?
Cellectricon AB, headquartered in Molndal, Sweden, provides research services that focus on neuroscience drug discovery.
Where is Cellectricon headquartered?
Cellectricon is headquartered in Molndal, Sweden.
Which VCs invest in companies like Cellectricon?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Cellectricon's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Cellectricon? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.